Education
About Us
Working with TipRanks
Follow Us
Harbor BioSciences (HRBR)
:HRBR
Total Valuation
Harbor BioSciences has a market cap or net worth of $29.21M. The enterprise value is $141.85M.
Market Cap$29.21M
Enterprise Value$141.85M
Share Statistics
Harbor BioSciences has 58,429,836 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding58,429,836
Owned by Insiders―
Owned by Institutions0.03%
Financial Efficiency
Harbor BioSciences’s return on equity (ROE) is -0.09 and return on invested capital (ROIC) is -14.34%.
Return on Equity (ROE)-0.09
Return on Assets (ROA)-0.07
Return on Invested Capital (ROIC)-14.34%
Return on Capital Employed (ROCE)-0.18
Revenue Per Employee197.62K
Profits Per Employee-15.86K
Employee Count1,008
Asset Turnover0.84
Inventory Turnover44.64
Valuation Ratios
The current PE Ratio of Harbor BioSciences is -5.62. Harbor BioSciences’s PEG ratio is -0.05.
PE Ratio-5.62
PS Ratio0.00
PB Ratio0.40
Price to Fair Value0.51
Price to FCF2.50
Price to Operating Cash Flow2.19
PEG Ratio-0.05
Income Statement
In the last 12 months, Harbor BioSciences had revenue of 199.21M and earned -15.98M in profits. Earnings per share was -0.39.
Revenue199.21M
Gross Profit-15.53M
Operating Income-36.87M
Pretax Income-19.35M
Net Income-15.98M
EBITDA10.39M
Earnings Per Share (EPS)-0.39
Cash Flow
In the last 12 months, operating cash flow was 8.46M and capital expenditures -4.42M, giving a free cash flow of 4.03M billion.
Operating Cash Flow8.46M
Free Cash Flow4.03M
Free Cash Flow per Share0.07
Dividends & Yields
Harbor BioSciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta17.09
52-Week Price Change-68.15%
50-Day Moving Average0.45
200-Day Moving Average0.73
Relative Strength Index (RSI)44.20
Average Volume (3m)7.96K
Important Dates
Harbor BioSciences upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Harbor BioSciences as a current ratio of 4.40, with Debt / Equity ratio of 31.27%
Current Ratio4.40
Quick Ratio4.24
Debt to Market Cap0.05
Net Debt to EBITDA-0.82
Interest Coverage Ratio-2.46K
Taxes
In the past 12 months, Harbor BioSciences has paid -3.37M in taxes.
Income Tax-3.37M
Effective Tax Rate0.17
Enterprise Valuation
Harbor BioSciences EV to EBITDA ratio is 7.82, with an EV/FCF ratio of -4.92.
EV to Sales0.41
EV to EBITDA7.82
EV to Free Cash Flow-4.92
EV to Operating Cash Flow-6.76
Balance Sheet
Harbor BioSciences has $102.40M in cash and marketable securities with $10.27M in debt, giving a net cash position of -$92.13M billion.
Cash & Marketable Securities$102.40M
Total Debt$10.27M
Net Cash-$92.13M
Net Cash Per Share-$1.58
Tangible Book Value Per Share$3.89
Margins
Gross margin is 25.23%, with operating margin of -18.51%, and net profit margin of -8.02%.
Gross Margin25.23%
Operating Margin-18.51%
Pretax Margin-9.71%
Net Profit Margin-8.02%
EBITDA Margin5.22%
EBIT Margin-9.71%
Analyst Forecast
The average price target for Harbor BioSciences is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―